Modulators of intracellular chloride concentration for treating down syndrome
US9822368B2 · kind B2 · utility
0Cited by
13References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 18, 2014 |
| Grant date | Nov 21, 2017 |
| Priority date | — |
| Expiry date | Jan 9, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Modulators of intracellular chloride concentration for treating down syndrome The present invention relates to a modulator of a chloride transporter for use in the treatment of Down syndrome.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.